世界の獣医感染症治療薬産業:成長傾向・競合分析2019-2025

【英語タイトル】Global Veterinary Infectious Diseases Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

QYResearchが出版した調査資料(QYR20FB12295)・商品コード:QYR20FB12295
・発行会社(調査会社):QYResearch
・発行日:2019年11月(※2024年版があります。お問い合わせください)
・ページ数:113
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートでは、世界の獣医感染症治療薬市場について調査・分析し、市場規模、市場動向、市場予測(~2025年)、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。獣医感染症治療薬の種類別には、抗生物質、抗ウイルス剤、抗真菌剤、アメーバ剤、駆虫薬に、用途別には、豚、鶏、犬、猫、牛、馬、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・獣医感染症治療薬の種類別市場規模:抗生物質、抗ウイルス剤、抗真菌剤、アメーバ剤、駆虫薬
・獣医感染症治療薬の用途別市場規模:豚、鶏、犬、猫、牛、馬、その他
・獣医感染症治療薬の地域別市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール:Elanco Animal Health、Novartis Animal Health、Merck、Pfizer Animal Health、Sanofi、Boehringer Ingelheim Vetmedica、Dechra Animal Health、Ceva Sante Animale、Elanco Animal Health、Virbac
・市場規模予測2019-2025:生産量
・市場規模予測2019-2025:消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...
【レポートの概要】

Veterinary infectious disease is a disease that can be transmitted from one animal to another or from another human being by pathogenic microorganisms.If not treated, will quickly infect animals, animals, will directly result in dairy, food and beverage industry, textile industry future risk, to food service industry, food industry, and families have a negative impact, not only pose a threat to animal veterinary infectious diseases, and pose a threat to humans, their treatment is widely used in veterinary hospital, veterinary clinic, the vet pharmacy, scientific research institutes.In 2018, the global Veterinary Infectious Diseases Therapeutics market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Veterinary Infectious Diseases Therapeutics.

This study researches the market size of Veterinary Infectious Diseases Therapeutics, presents the global Veterinary Infectious Diseases Therapeutics sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Veterinary Infectious Diseases Therapeutics in key regions like North America, Europe, China and Japan, presents sales, revenue, market share, growth rate of Veterinary Infectious Diseases Therapeutics for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Elanco Animal Health
Novartis Animal Health
Merck
Pfizer Animal Health
Sanofi
Boehringer Ingelheim Vetmedica
Dechra Animal Health
Ceva Sante Animale
Elanco Animal Health
Virbac

Market Segment by Product Type
Antibiotics
Antiviral
Antifungal
Amebicides
Anthelmintics

Market Segment by Application
Swine
Chicken
Dog
Cat
Cow
Horse
Other

Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Veterinary Infectious Diseases Therapeutics status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Veterinary Infectious Diseases Therapeutics manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Veterinary Infectious Diseases Therapeutics are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Type
1.3.2 Antibiotics
1.3.3 Antiviral
1.3.4 Antifungal
1.3.5 Amebicides
1.3.6 Anthelmintics
1.4 Market Segment by Application
1.4.1 Global Veterinary Infectious Diseases Therapeutics Market Share by Application (2019-2025)
1.4.2 Swine
1.4.3 Chicken
1.4.4 Dog
1.4.5 Cat
1.4.6 Cow
1.4.7 Horse
1.4.8 Other
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Veterinary Infectious Diseases Therapeutics Market Size
2.1.1 Global Veterinary Infectious Diseases Therapeutics Revenue 2014-2025
2.1.2 Global Veterinary Infectious Diseases Therapeutics Sales 2014-2025
2.2 Veterinary Infectious Diseases Therapeutics Growth Rate by Regions
2.2.1 Global Veterinary Infectious Diseases Therapeutics Sales by Regions 2014-2019
2.2.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Veterinary Infectious Diseases Therapeutics Sales by Manufacturers
3.1.1 Veterinary Infectious Diseases Therapeutics Sales by Manufacturers 2014-2019
3.1.2 Veterinary Infectious Diseases Therapeutics Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Veterinary Infectious Diseases Therapeutics Revenue by Manufacturers (2014-2019)
3.2.2 Veterinary Infectious Diseases Therapeutics Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Veterinary Infectious Diseases Therapeutics Market Concentration Ratio (CR5 and HHI)
3.3 Veterinary Infectious Diseases Therapeutics Price by Manufacturers
3.4 Key Manufacturers Veterinary Infectious Diseases Therapeutics Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Veterinary Infectious Diseases Therapeutics Market
3.6 Key Manufacturers Veterinary Infectious Diseases Therapeutics Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Antibiotics Sales and Revenue (2014-2019)
4.1.2 Antiviral Sales and Revenue (2014-2019)
4.1.3 Antifungal Sales and Revenue (2014-2019)
4.1.4 Amebicides Sales and Revenue (2014-2019)
4.1.5 Anthelmintics Sales and Revenue (2014-2019)
4.2 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type
4.3 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type
4.4 Veterinary Infectious Diseases Therapeutics Price by Type

5 Market Size by Application
5.1 Overview
5.1 Global Veterinary Infectious Diseases Therapeutics Sales by Application

6 North America
6.1 North America Veterinary Infectious Diseases Therapeutics Breakdown Data by Company
6.2 North America Veterinary Infectious Diseases Therapeutics Breakdown Data by Type
6.3 North America Veterinary Infectious Diseases Therapeutics Breakdown Data by Application
6.4 North America Veterinary Infectious Diseases Therapeutics Breakdown Data by Countries
6.4.1 North America Veterinary Infectious Diseases Therapeutics Sales by Countries
6.4.2 North America Veterinary Infectious Diseases Therapeutics Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Veterinary Infectious Diseases Therapeutics Breakdown Data by Company
7.2 Europe Veterinary Infectious Diseases Therapeutics Breakdown Data by Type
7.3 Europe Veterinary Infectious Diseases Therapeutics Breakdown Data by Application
7.4 Europe Veterinary Infectious Diseases Therapeutics Breakdown Data by Countries
7.4.1 Europe Veterinary Infectious Diseases Therapeutics Sales by Countries
7.4.2 Europe Veterinary Infectious Diseases Therapeutics Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Veterinary Infectious Diseases Therapeutics Breakdown Data by Company
8.2 Asia Pacific Veterinary Infectious Diseases Therapeutics Breakdown Data by Type
8.3 Asia Pacific Veterinary Infectious Diseases Therapeutics Breakdown Data by Application
8.4 Asia Pacific Veterinary Infectious Diseases Therapeutics Breakdown Data by Regions
8.4.1 Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Countries
8.4.2 Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Veterinary Infectious Diseases Therapeutics Breakdown Data by Company
9.2 Central & South America Veterinary Infectious Diseases Therapeutics Breakdown Data by Type
9.3 Central & South America Veterinary Infectious Diseases Therapeutics Breakdown Data by Application
9.4 Central & South America Veterinary Infectious Diseases Therapeutics Breakdown Data by Countries
9.4.1 Central & South America Veterinary Infectious Diseases Therapeutics Sales by Countries
9.4.2 Central & South America Veterinary Infectious Diseases Therapeutics Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Veterinary Infectious Diseases Therapeutics Breakdown Data by Type
10.2 Middle East and Africa Veterinary Infectious Diseases Therapeutics Breakdown Data by Application
10.3 Middle East and Africa Veterinary Infectious Diseases Therapeutics Breakdown Data by Countries
10.3.1 Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Countries
10.3.2 Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa

11 Company Profiles
11.1 Elanco Animal Health
11.1.1 Elanco Animal Health Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Veterinary Infectious Diseases Therapeutics
11.1.4 Veterinary Infectious Diseases Therapeutics Product Introduction
11.1.5 Elanco Animal Health Recent Development
11.2 Novartis Animal Health
11.2.1 Novartis Animal Health Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Veterinary Infectious Diseases Therapeutics
11.2.4 Veterinary Infectious Diseases Therapeutics Product Introduction
11.2.5 Novartis Animal Health Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Veterinary Infectious Diseases Therapeutics
11.3.4 Veterinary Infectious Diseases Therapeutics Product Introduction
11.3.5 Merck Recent Development
11.4 Pfizer Animal Health
11.4.1 Pfizer Animal Health Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Veterinary Infectious Diseases Therapeutics
11.4.4 Veterinary Infectious Diseases Therapeutics Product Introduction
11.4.5 Pfizer Animal Health Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Veterinary Infectious Diseases Therapeutics
11.5.4 Veterinary Infectious Diseases Therapeutics Product Introduction
11.5.5 Sanofi Recent Development
11.6 Boehringer Ingelheim Vetmedica
11.6.1 Boehringer Ingelheim Vetmedica Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Veterinary Infectious Diseases Therapeutics
11.6.4 Veterinary Infectious Diseases Therapeutics Product Introduction
11.6.5 Boehringer Ingelheim Vetmedica Recent Development
11.7 Dechra Animal Health
11.7.1 Dechra Animal Health Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Veterinary Infectious Diseases Therapeutics
11.7.4 Veterinary Infectious Diseases Therapeutics Product Introduction
11.7.5 Dechra Animal Health Recent Development
11.8 Ceva Sante Animale
11.8.1 Ceva Sante Animale Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Veterinary Infectious Diseases Therapeutics
11.8.4 Veterinary Infectious Diseases Therapeutics Product Introduction
11.8.5 Ceva Sante Animale Recent Development
11.9 Elanco Animal Health
11.9.1 Elanco Animal Health Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Veterinary Infectious Diseases Therapeutics
11.9.4 Veterinary Infectious Diseases Therapeutics Product Introduction
11.9.5 Elanco Animal Health Recent Development
11.10 Virbac
11.10.1 Virbac Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Veterinary Infectious Diseases Therapeutics
11.10.4 Veterinary Infectious Diseases Therapeutics Product Introduction
11.10.5 Virbac Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Veterinary Infectious Diseases Therapeutics Sales Channels
12.2.2 Veterinary Infectious Diseases Therapeutics Distributors
12.3 Veterinary Infectious Diseases Therapeutics Customers

13 Market Forecast
13.1 Global Veterinary Infectious Diseases Therapeutics Sales and Revenue Forecast 2019-2025
13.2 Global Veterinary Infectious Diseases Therapeutics Sales Forecast by Type
13.3 Global Veterinary Infectious Diseases Therapeutics Sales Forecast by Application
13.4 Veterinary Infectious Diseases Therapeutics Forecast by Regions
13.4.1 Global Veterinary Infectious Diseases Therapeutics Sales Forecast by Regions 2019-2025
13.4.2 Global Veterinary Infectious Diseases Therapeutics Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Veterinary Infectious Diseases Therapeutics Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Veterinary Infectious Diseases Therapeutics Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Veterinary Infectious Diseases Therapeutics Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Veterinary Infectious Diseases Therapeutics Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer



【掲載企業】

Elanco Animal Health、Novartis Animal Health、Merck、Pfizer Animal Health、Sanofi、Boehringer Ingelheim Vetmedica、Dechra Animal Health、Ceva Sante Animale、Elanco Animal Health、Virbac

★調査レポート[世界の獣医感染症治療薬産業:成長傾向・競合分析2019-2025] (コード:QYR20FB12295)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の獣医感染症治療薬産業:成長傾向・競合分析2019-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆